(Q51838030)

13 April 2018

title

Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women. (English)

1 reference

13 April 2018

author

Jianlin Zhou

7

1 reference

13 April 2018

author name string

Zhifeng Sheng

1

1 reference

13 April 2018

Dejun Tong

2

1 reference

13 April 2018

Yangna Ou

3

1 reference

13 April 2018

Hongbin Zhang

4

1 reference

13 April 2018

Zhimin Zhang

5

1 reference

13 April 2018

Shuang Li

6

1 reference

13 April 2018

Jian Zhang

8

1 reference

13 April 2018

Eryuan Liao

9

1 reference

13 April 2018

publication date

1 June 2012

1 reference

13 April 2018

published in

Clinical Endocrinology

1 reference

13 April 2018

volume

76

1 reference

13 April 2018

issue

6

1 reference

13 April 2018

page(s)

797-801

1 reference

13 April 2018

Relationship of body composition with prevalence of osteoporosis in central south Chinese postmenopausal women

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04315.X

Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04315.X

Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04315.X

Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04315.X

Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04315.X

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04315.X

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04315.X

Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04315.X

Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04315.X

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04315.X

Determination of serum and plasma sclerostin concentrations by enzyme-linked immunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04315.X

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04315.X

Relationship between body composition and bone mineral density in women with and without osteoporosis: relative contribution of lean and fat mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04315.X

Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04315.X

Treatment with a sclerostin antibody increases cancellous bone formation and bone mass regardless of marrow composition in adult female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04315.X

10.1111/J.1365-2265.2011.04315.X

21 January 2018

Identifiers

DOI

1 reference

13 April 2018

1 reference

13 April 2018